Smart manufacturing and R&D commercialisation at Monash enhanced by $16.12 million investment

1 September 2021

Smart manufacturing, and research and development commercialisation at Monash, will be enhanced by a $16.12 million investment through the Victorian Higher Education State Investment Fund (VHESIF).

The investment will deliver far-reaching benefits to the Victorian community by enhancing research commercialisation, supporting the creation of future industries and jobs, accelerating the attraction of international investment, and building access to global supply chains.

Monash’s leadership in advanced manufacturing, biomedical innovation and pharmaceutical sciences will deliver job growth, and drive economic prosperity for the Victorian industry and community.

The funding will support investment integration to maximise impact in three core areas across the Monash Technology Precinct by June 2022, including Medicines Manufacturing Innovation Centre (MMIC). This funding will support the expansion of MMIC's presence to a new node at Clayton, allowing the scale-up of medicine manufacturing capability, and support for clinical trials and growth of exports and jobs.

Read the full story here.